Drugs / NAB001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01208129 | Sep 2010 → Jul 2012 | fungal infection of the toenail | Promius Pharma, LLC | Terminated | No outcome recorded |
| Phase 3 | NCT01208168 | Sep 2010 → Jul 2012 | tinea unguium | Promius Pharma, LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAB001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01208168 ↗ |
| Route | Topical | “topical treatment” NCT01208129 ↗ |